# Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium
> **Food and Drug Administration** · Final rule. · Published 2010-01-11 · Effective 2010-01-11 · 75 FR 1274
## Document
- **Document number:** 2010-207
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 75 FR 1274
- **CFR reference:** 21 CFR 522
- **Publication date:** 2010-01-11
- **Effective date:** 2010-01-11
- **HHS docket:** Docket No. FDA-2009-N-0665
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Anika Therapeutics, Inc. The supplemental NADA provides for a revised human food safety warning for use of hyaluronate sodium injectable solution in horses.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2010/01/11/2010-207/implantation-or-injectable-dosage-form-new-animal-drugs-hyaluronate-sodium)
---
*AI Analytics · CC0 1.0*